Century Therapeutics Inc

NAS:IPSC (USA)  
$ 1.02 +0.005 (+0.49%) 11:08 PM EST
At Loss
P/B:
0.44
Market Cap:
$ 87.16M
Enterprise V:
$ -56.36M
Volume:
516.02K
Avg Vol (2M):
667.03K
Trade In:
Volume:
516.02K
At Loss
Avg Vol (2M):
667.03K

Business Description

Century Therapeutics Inc
NAICS : 541714 SIC : 2833
ISIN : US15673T1007
Description
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
Name Current Vs Industry Vs History
Cash-To-Debt 3.63
Equity-to-Asset 0.5
Debt-to-Equity 0.28
Debt-to-EBITDA -0.47
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.95
Distress
Grey
Safe
Beneish M-Score -3.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -18.1
3-Year EPS without NRI Growth Rate -18.5
3-Year FCF Growth Rate -12.1
Name Current Vs Industry Vs History
5-Day RSI 23.18
9-Day RSI 28.62
14-Day RSI 33.77
6-1 Month Momentum % -54.85
12-1 Month Momentum % -50

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.39
Quick Ratio 10.39
Cash Ratio 10

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.2
Shareholder Yield % -90.01

Financials (Next Earnings Date:2025-03-14 Est.)

IPSC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IPSC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Century Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.685
EPS (TTM) ($) -1.85
Beta 1.88
Volatility % 167.67
14-Day RSI 33.77
14-Day ATR ($) 0.126753
20-Day SMA ($) 1.33
12-1 Month Momentum % -50
52-Week Range ($) 0.9501 - 5.51
Shares Outstanding (Mil) 85.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Century Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Century Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Century Therapeutics Inc Frequently Asked Questions

What is Century Therapeutics Inc(IPSC)'s stock price today?
The current price of IPSC is $1.02. The 52 week high of IPSC is $5.51 and 52 week low is $0.95.
When is next earnings date of Century Therapeutics Inc(IPSC)?
The next earnings date of Century Therapeutics Inc(IPSC) is 2025-03-14 Est..
Does Century Therapeutics Inc(IPSC) pay dividends? If so, how much?
Century Therapeutics Inc(IPSC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1